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http://www.biomedcentral.com/1471-2474/15/151RESEARCH ARTICLE Open AccessHigh short-term and long-term excess mortality
in geriatric patients after hip fracture: a prospective
cohort study in Taiwan
Li-Wei Hung1, Wo-Jan Tseng2, Guey-Shiun Huang3 and Jinn Lin1*Abstract
Background: Hip fracture has a high mortality rate, but the actual level of long-term excess mortality and its impact
on population-wide mortality remains controversial. The present prospective study investigated short- and long-term
excess mortality after hip fractures with adjustment of other risk factors. We calculated the population attributable risk
proportion (PARP) to assess the impact of each risk factor on excess mortality.
Methods: We recruited 217 elders with hip fractures and 215 age- and sex-matched patients without fractures from
the geriatric department of the same hospital. The mean follow-up time was 46.1 months (range: 35 to 57 months).
We recorded data on 55 covariates, including baseline details about health, function, and bone mineral density. We
used the multivariate Cox proportional hazards model to analyze hazard ratios (HRs) of short-term (<12 months
follow-up) and long-term (≧12 months follow-up) excess mortality for each covariate and calculated their PARP.
Results: Patients with hip fractures had a higher short-term mortality than non-fractured patients, and the long-term
excess mortality associated with hip fracture remained high. The significant risk factors for short-term mortality were
hip fracture, comorbidities, and lower (below cutoff) Mini Mental State Examination score with HRs of 2.4, 2.3, and 2.3,
respectively. Their PARPs were 44.7%, 38.1%, and 34.3%, respectively. The significant risk factors for long-term mortality
were hip fracture (HR: 2.7; PARP: 48.0%), lower T-score (HR: 3.3; PARP: 36.2%), lower body mass index (HR: 2.5; PARP:
42.8%), comorbidities (HR: 2.1; PARP: 34.8%), difficulty in activities of daily living (HR: 1.9; PARP: 31.8%), and smoking
(HR: 2.5; PARP: 19.2%).
Conclusions: After comprehensive adjustment, hip fracture was a significant risk factor and contributed the most to
long-term as well as short-term excess mortality. Its adequate prevention and treatment should be targeted.
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Hip fractures are a major cause of mortality in the elderly.
Over 80% of such injuries are caused by low-energy
trauma in patients with underlying osteoporosis [1,2]. Glo-
bally, 1.6 million osteoporotic hip fractures and 740,000
deaths associated with this injury per year have been re-
ported [3]. Although the incidence of hip fractures has
been decreasing in some regions, such as North America
and Australia, it is still increasing in Asia, Latin America,
the Middle East, and some parts of Europe [4,5]. Given* Correspondence: jinn@ntu.edu.tw
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unless otherwise stated.the global increase in the elderly population and the rising
number of patients with osteoporosis, the social and eco-
nomic burden caused by hip fractures is likely to become
enormous [3,4,6].
Higher mortality immediately after hip fracture is well
documented, and almost all studies have reported sig-
nificant short-term excess mortality after this injury [7-12].
Excess mortality after hip fracture is defined as a death rate
that is higher than that in the population without hip frac-
ture. The risk of death decreases with time, but how long
exactly the excess mortality persists after hip fracture has
not been settled. Some suggest it does not last long
[13-16], while others say it may persist for as long as
10 years [12,17,18].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tially associated with excess mortality after hip fracture.
But the impact of specific risk factors on excess mortal-
ity has not been adequately studied. The purpose of our
study was three-fold: to investigate short- and long-term
excess mortality after hip fractures, to explore the risk
factors of excess mortality, and to calculate the popula-
tion attributable risk proportion (PARP) for each risk fac-
tor. This PARP represented the impact of each risk factor
on excess mortality of population after hip fracture.
Methods
Ethics statement
The human ethical committees of National Taiwan
University Hospital (9361700433) and National Health
Research Institutes (EC 0930307) approved this study.
We obtained written consent from all study participants.
Study participants
This prospective observational study included patients
with and without hip fracture treated at the National
Taiwan University Hospital. Included in the group with
hip fractures were patients aged 60 years or older who
had a hip fracture. Excluded from the study were pa-
tients with pathologic fracture, with previous hip frac-
ture, with previous surgery on the fractured hip, whose
fracture was not related to low energy trauma, or who
were institutionalized. Low-energy trauma is defined as
injury resulting from a transfer of energy that is equal to
or less than that of a fall from a standing position. Be-
tween April 1, 2004, and January 31, 2006, we recruited
376 consecutive patients with hip fractures in our hos-
pital. After exclusion of 76 patients with previous hip
fractures or surgeries, 25 patients whose fracture was
not from low-energy trauma, and 13 institutionalized pa-
tients, there were 262 eligible patients, among whom
217 agreed to join the study. We tracked the cohort
through 2008 for mortality outcome.
Two orthopedic surgeons reviewed the plain films of
the injured hips, and they made the diagnosis of hip
fracture by consensus. Non-displaced or impacted cer-
vical fractures were fixed with multiple pins or compres-
sion hip screws. Displaced cervical fractures were treated
with hemiarthroplasty. Fractures over the trochanteric re-
gion were fixed with compression hip screws or cephao-
medullary nails. All patients in the study group were
interviewed for demographic and clinical data when their
condition was stable, usually within 6 days on average
(range: 1 to 27 days) after the fracture. Stable condition
meant that the patient began to be mobilized and could
respond to questions.
We recruited the group without hip fractures from the
patients in the Geriatrics Department of the same hospital.
As soon as a patient with a hip fracture was enrolled inthe study, we matched him or her with a non-fracture
patient from the hospitalization list of the Geriatrics
Department on the basis of age (mostly within 4 years, but
up to 6 years in 13 patients older than 90 years for whom
it was difficult to find controls) and sex. At the end of the
study enrollment period, 215 patients were matched. The
non-fracture patients were interviewed at an average of
17.5 days after the interview of the matched study
patient.
Mortality data
The date of death of the participants in both groups was
obtained from the National Death Registry database,
which includes the survival status of all citizens and is
updated annually. We defined short-term mortality as
death occurring less than 12 months after hip fracture
and long-term mortality as death occurring 12 months
or longer after hip fracture. To evaluate long-term mor-
tality, we continued to follow the study participants who
survived 12 months. The mean follow-up period was
46.1 months (range: 35 to 57 months). The mean sur-
vival time was 21 months (range: 3 days to 52 months)
for mortality patients and 45.9 months (range: 35 to
57 months) for survival patients.
Covariates
We included 55 covariates in our study (Table 1). All are
important factors that might influence mortality status
after hip fracture, according to previous studies and our
own clinical experience. For consistent data gathering,
trained study nurses used the same standardized ques-
tionnaire to interview patients in the hip fracture and
the non-fracture groups. They collected information
from patients or their proxy on demographics, self-
reports of a physician’s diagnosis of underlying disease,
current medications, health habits, nutritional supple-
ments, cognitive function, physical functions, and liv-
ing environment. Patients with a diagnosis of cancer,
heart failure, angina pectoris, arrhythmia, liver disease,
Parkinson's disease, or osteoarthritis were defined as
participants with comorbidity. Bone mineral density
(BMD) scans were arranged for all participants, and
341 of them agreed to the examination. All BMD data
were measured by the dual-energy X-ray absorptiometry
machine (Model: QDR4500A; Hologic, Waltham, MA,
USA). T-scores were based on the total hip BMD (g/cm2)
of the non-fractured side of the hip.
Statistical analysis
We used the Kaplan-Meier survival curve to analyze the
mortality rates of the fracture and non-fracture patients,
and then compared them using the log rank test. To
study how the covariates affect short- and long-term ex-
cess mortality, we used the Cox proportional hazards
Table 1 Covariates representing the patient’s condition before hip fracture
Type Covariates
Demography Age, sex, ethnicity, occupation, marital status, living arrangements
Cancer, heart failure, angina pectoris, arrhythmia, liver disease, Parkinson's disease, osteoarthritis
Medication Antihypertensive, cardiovascular medications, analgesics, anti-diabetes, psychotropics, gastrointestinal,
other medications, polypharmacy (≥4 medications)
Health habits Cigarette smoking, alcohol intake, betel nut chewing, leisure time physical activity
Diet and nutrition Vegetarian diet, use of milk, coffee, tea; use of nutritional supplements such as calcium, multivitamin, and
glucosamine
Falls and fracture History of fall, history of fall-induced fracture, locations of fracture, place, and time that fall happened
Living environment Building type, floor on which the participant lived, number of stairs in a flight, self-evaluation of stair
height, stair lighting, outdoor lighting, green light duration
Physical functions ADL [19]: eating, bathing, dressing, toileting, getting in and out of bed
IADL [20]: preparing a meal, shopping, using a telephone, taking medicine, light and heavy housework
Mobility tasks [21]: bending, walking from room to room, walking up 10 steps, walking a quarter of a mile,
grasping, lifting 10 pounds, raising arms over head, unlocking with a key
Hearing and visual ability, finger-nose-finger coordination [22]
Cognitive functions MMSE [23]
Anthropometric Body height, body weight, BMI
Other BMD (T-score)
ADL: activities of daily living; IADL: instrumental activities of daily living; MMSE: Mini Mental State Examination; BMI: body mass index; BMD: bone mineral density.
The 55 covariates were shown in bold type.
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and 95% confidence intervals (CIs) for the covariates.
We defined death as the outcome event and survival
time as the duration from hip fracture to the date of
death. Patients’ data were censored if they were still alive
at the end of the study. First, we used the model to test
the unadjusted HRs of all 55 covariates for the entire
follow-up period. Significant continuous covariates in
the first model were converted to dichotomous variables
using a cutoff value determined by the Youden index cre-
ated by a receiver operating characteristic (ROC) curve [24].
The cutoff values of the significant continuous covari-
ates were 84 years for age, 19 for Mini Mental State
Examination (MMSE) score, −2.19 for T-score, and 20
for body mass index (BMI). We tested these covariates
using graphical methods, all of which were compatible
with the proportional hazards assumption. Univariate ana-
lysis using the Cox proportional hazards model was per-
formed to test the unadjusted HRs of each covariate both
for short-term and long-term excess mortality. The signifi-
cant covariates generated in univariate analysis were then
entered into the next model.
We performed multivariate analysis using forward
stepwise Cox regression model to calculate the adjusted
HRs. With p values set at 0.05 for entry and 0.1 for re-
moval, the adjusted HRs were generated in this model.
The PARP indicated that the rate of death in the entire
population could be reduced if the risk factor for excess
mortality were absent [25,26]. The PARPs were deter-
mined according to the adjusted HRs and calculated asP × [HR-1]/HR, where P is the exposed number of patients
who died divided by the total number of patients who
died. All analyses used the SPSS software (statistical soft-
ware package for Windows version 19.0, IBM, Chicago,
IL, USA) and the MedCalc software program (version
11.2, MedCalc, Mariakerke, Belgium).
Results
Among the 432 patients enrolled in the study, 305 (70.6%)
were women, and the mean age of all patients was 79.3 ±
7.5 years, with a range of 60 to 99 years. Patients with hip
fracture had significantly lower BMI, T-score, and MMSE;
worse activities of daily living (ADL) function, instrumen-
tal activities of daily living (IADL) function, coordination,
and mobility function; less coffee drinking; and less
participation in physical exercise than did their age- and
sex-matched controls (Table 2). There were no significant
differences in the proportions of having comorbidity and
smoking.
During the follow-up, there were 93 (21.5%) deaths for
all the enrolled patients. Among them, 75 (34.6%) pa-
tients with hip fractures died versus 18 (8.4%) patients
without fractures. The Kaplan-Meier survival curve of
the hip fracture group declined after the first month of
follow-up and significantly diverged from the curve of
the non-fracture group (Figure 1). In the short-term
mortality study, the overall mortality rate was 8.1%. In
the hip fracture group, 12.4% of those patients died
versus 3.7% in the non-fracture group (HR 3.5; 95%
CI 1.6-7.6).
Table 2 General characteristics of the study population
Variable* Overall (%) Hip fractures (%) Non-Hip
fractures (%)
p value
Age (years) Matched
≤ 84 329 (76.2%) 147 (67.7%) 182 (84.7%)
> 84 103 (23.8%) 70 (32.3%) 33 (15.3%)
Sex Matched
Female 305 (70.6%) 156 (71.9%) 149 (69.3%)
Male 127 (29.4%) 61 (28.1%) 66 (30.7%)
BMI
>20 350 (81.0%) 160 (73.7%) 190 (88.4%)
≤20 82 (19.0%) 57 (26.3%) 25 (11.6%) <0.001
T-score
> −2.19 199 (46.1%) 49 (22.6%) 150 (69.8%)
≤ −2.19 142 (32.9%) 95 (43.8%) 47 (21.9%) <0.001
Missing 91 (21.1%) 73 (33.6%) 18 (8.4%)
MMSE
>19 270 (62.5%) 102 (47.0%) 168 (78.1%)
≤ 19 162 (37.5%) 115 (53.0%) 47 (21.9%) <0.001
ADL difficulty
No 346 (80.1%) 157 (72.4%) 189 (87.9%)
Yes 86 (19.9%) 60 (27.6%) 26 (12.1%) <0.001
Coordination abnormality
No 376 (87.0%) 175 (80.6%) 201 (93.5%)
Yes 56 (13.0%) 42 (19.4%) 14 (6.5%) <0.001
Weight-bearing exercise in past 2 weeks
No 204 (47.2%) 118 (54.4%) 86 (40.0%)
Yes 228 (52.8%) 99 (45.6%) 129 (60.0%) 0.003
Coffee drinking
No 312 (72.2%) 176 (81.1%) 136 (63.3%)
Yes 120 (27.8%) 41 (18.9%) 79 (36.7%) <0.001
Comorbidity
No 214 (49.5%) 99 (45.6%) 115 (53.5%)
Yes 218 (50.5%) 118 (54.4%) 100 (46.5%) 0.124
Smoking
No 325 (75.2%) 160 (73.7%) 165 (76.7%)
Yes 107 (24.8%) 57 (26.3%) 50 (23.3%) 0.504
BMI: body mass index; MMSE: Mini Mental State Examination; ADL: activities of
daily living.
*Only age, sex, the variables with significant difference between two groups
and the significant variables affecting the excess mortality were listed.
Figure 1 Kaplan-Meier survival curve. Five-year Kaplan-Meier estimates
of cumulative probability of survival after hospital admission for
hip fracture. Each vertical tick mark indicates a follow-up month
in which patient censoring took place.
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term mortality in univariate analyses, three covariates
remained significant in the forward stepwise Cox regres-
sion model (Table 3): hip fracture (HR 2.4; 95% CI 1.1-
5.4), presence of comorbidity (HR 2.3; 95% CI 1.1-4.7),
and lower MMSE score (HR 2.3; 95% CI 1.1-4.8).The 397 patients who survived through the first year
were further evaluated for long-term mortality. The over-
all long-term mortality was 14.6%, with 25.2% of the pa-
tients in the hip fracture group dying versus 4.8% in the
non-fracture group (HR 5.4; 95% CI 2.7-10.7).
Of the eleven significant factors contributing to long-
term mortality, six covariates remained significant in the
forward stepwise Cox regression model (Table 4): hip
fracture (HR 2.7; 95% CI 1.3-5.6), lower T score (HR 3.3;
95% CI 1.4-7.8), lower BMI (HR 2.5; 95% CI 1.4-4.3), the
presence of comorbidity (HR 2.1; 95% CI 1.9-3.6), ADL
difficulty (HR 1.9; 95% CI 1.1-3.4), and smoking (HR 2.5;
95% CI 1.4-4.4).
In PARP analyses, after adjusting for other significant
risk factors, the risk factor contributing the most to ex-
cess mortality was hip fracture, with a PARP of 44.7%
for short-term excess mortality and 48% for long-term
excess mortality. The PARPs for other factors contribut-
ing to short-term excess mortality were 38.1% for co-
morbidity and 34.3% for lower MMSE. The PARPs for
other factors contributing to long-term excess mortality
were 42.8% for lower BMI, 36.2% for lower T-score,
34.8% for comorbidity, 31.8% for ADL difficulties, and
19.2% for smoking.
Discussion
In this prospective, hospital-based cohort study for hip
fractures among the elderly, survival analyses showed a
higher short- and long-term excess mortality in the hip
fracture patients than the sex- and age-matched non-
fractured patients. After adjustment for other potential
Table 3 Cox regression analysis showing hazard ratio for short-term mortality after hip fracture
Variable Survivals (%) Deaths (%) Unadjusted HR (CI) p value Adjusted HR* (CI) p value PARP (CI)
Hip fracture
No 207 (96.3) 8 (3.7) 1.0 1.0
Yes 190 (87.6) 27 (12.4) 3.4 (1.6-7.7) 0.002 2.4 (1.1-5.4) 0.037 44.7% (3.3-74.1)
Comorbidity
No 203 (94.9) 11 (5.1) 1.0 1.0
Yes 194 (89.0) 24 (11.0) 2.2 (1.1-4.5) < 0.001 2.3 (1.1-4.7) 0.028 38.1% (4.5-65.0)
MMSE
> 19 258 (95.6) 12 (4.4) 1.0 1.0
≤ 19 139 (85.8) 23 (14.2) 3.3 (1.7-6.8) < 0.001 2.3 (1.1-4.8) 0.022 34.3% (5.6-64.0)
HR: Hazard ratio; CI: 95% confidence intervals; PARP: population attributable risk proportion; MMSE: Mini Mental State Examination.
*Multivariate adjustment for the significant risk factors in univariate analysis; only significant variables in this model were listed. Lower body mass index and lower
T-score were only significant in univariate analyses.
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still a significant risk factor and contributed the most to
both short-term and long-term excess mortality.
Mortality rate as a direct and simple summary of mor-
tality information can be a general indicator of the health
status of a geographic area or population. In the present
study, the short-term and long-term morality rates in the
hip fracture population were 12.4% and 25.3%, respect-
ively. Both rates were somewhat lower than almost allTable 4 Cox regression analysis showing hazard ratios for lon
Variable* Survivals (%) Deaths (%) Unadjusted HR (CI)
Hip fracture
No 197 (95.2) 10 (4.8) 1.0
Yes 142 (74.7) 48 (25.3) 5.4 (2.7-10.7)
BMI
> 20 45 (64.3) 25 (35.7) 1.0
≤ 20 294 (89.9) 33 (10.1) 4.0 (2.4-6.8)
T-score
> −2.19 183 (95.3) 9 (4.7) 1.0
≤ −2.19 93 (75.6) 30 (24.4) 6.1 (2.9-12.9)
Missing 63 (76.8) 19 (23.2) 5.8 (2.6-12.8)
Comorbidity
No 184 (90.6) 19 (9.4) 1.0
Yes 155 (79.9) 39 (20.1) 2.3 (1.3-4.0)
ADL difficulty
No 288 (89.4) 34 (10.6) 1.00
Yes 51 (68.0) 24 (32.0) 3.4 (2.0-5.7)
Smoking
No 265 (87.5) 38 (12.5) 1.0
Yes 74 (78.7) 20 (21.3) 1.7 (1–2.9)
HR: Hazard ratio; CI: 95% confidence intervals; PARP: population attributable risk pro
*Multivariate adjustment for all other significant risk factors in univariate analysis; o
lower Mini Mental State Examination score, older age, vegetarian diet, and less partthose previously reported, which might be up to 50% and
52%, respectively [8-12,16,27]. The difference might be ex-
plained by better care in a medical center like our hospital,
in which the patients received high quality care given by
experts from a wide range of medical specialities. It should
be noted that the short-term mortality rate has also been
reported to be as low as 9.2% [28], which may be attribut-
able to long hospital stay [29]. Mortality rate alone, how-
ever, does not reflect how many excess deaths areg-term mortality after hip fracture
p value Adjusted HR* (CI) p value PARP (CI)
1.0
< 0.001 2.7 (1.3-5.6) 0.007 48.0% (17.5-75.9)
1.0
< 0.001 2.5 (1.4-4.3) 0.002 42.8% (12.8-53.5)
1.0
<0.001 3.3 (1.4-7.8) 0.017 36.2% (11.7-56.2)
3.3 (1.3-7.4)
1.0
0.003 2.1 (1.9-3.6) 0.011 34.8% (8.6-57.4)
1.0
< 0.001 1.9 (1.1-3.4) 0.017 31.8% (3.1-37.9)
1.0
0.051 2.5 (1.4-4.4) 0.001 19.2%
(6.7-36.1)
portion; BMI: body mass index; ADL: activities of daily living.
nly significant variables in this model were listed. Coordination abnormality,
icipation in physical exercise were only significant in univariate analyses.
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mation on the relative importance of the injury.
The excess mortality rate is more meaningful clinically
than the mortality rate alone. Quantification of add-
itional deaths makes it possible to evaluate the relative
influence of hip fracture or other risk factors on the
mortality of patients. It can be expressed as an absolute
effect or a relative effect. Absolute effect is the actual
difference in the mortality risk between an exposed and
an unexposed population. Relative effect is expressed by
the hazard ratio of the mortality risk between an ex-
posed and an unexposed population. The absolute effect
provides straightforward information about excess mortal-
ity that is particularly useful when considering trade-offs
between likely benefits and likely harms of an intervention
[30]. Still, the clinical importance of the excess mortality
may depend more on the relative effect than the absolute
effect alone, especially when the mortality rate is low [31].
In the present study, for short-term excess mortality,
the absolute effect was 8.7%, but the relative effect could
be up to 3.4-fold. For long-term excess mortality, the ab-
solute effect was 20.5%, but the relative effect was up to
5.4-fold. This relative effect provides more information
on the importance of the hip fractures and has the add-
itional advantage of allowing a direct comparison among
different studies. In contrast to absolute effect, relative
effect can also be adjusted by the inclusion of other com-
peting risk factors through multivariate analysis [32].
Although studies have consistently reported significant
short-term excess mortality after hip fractures [1,14-18,33-35],
reports of long-term excess mortality have widely varied.
Some studies that adjusted only for age and sex reported
hip fracture was a significant risk factor for long-term ex-
cess mortality, but their conclusions may be biased be-
cause of the absence of adjustment for other potential risk
factors [7,12,17,33]. Some other studies that did adjust for
the potential risk factors found that hip fracture was statis-
tically significant for long-term excess mortality [18,35-37],
while others had an opposite finding. [13,14,27]. All of
these studies used secondary data from the disease registry,
hospital records, or data that were not originally collected
for the purpose of studying excess mortality. Consequently,
information on risk factors collected in these studies might
not be comprehensive enough to allow adequate adjust-
ment. Moreover, in the secondary data, the conditions of
the patients recorded at the beginning of data collection
might have changed by the time of the hip fracture and
thus could affect the accuracy and reliability of the study
results. To date, there has been a lack of primary data
studying long-term excess mortality of hip fractures and
our report helps fill that gap in knowledge.
Another issue related to assessment of long-term excess
morality in patients with hip fracture has to do with the op-
timal selection of the control group. Most reported excessmortality studies compared hip fracture patients with a
healthy general population. However, hip fracture patients
have worse health conditions than general population. The
problem with using these two groups for comparison is
that the significance of the hip fracture might be con-
founded by comorbidities [14,38]. In our study, hip fracture
patients were compared with hospitalized non-fracture pa-
tients recruited from the geriatric department. The percent-
age of patients with comorbidities was similar in these two
groups (54.4% vs. 46.5%, p = 0.124). By ensuring that the
study subjects were relatively homogeneous, we maximized
the chance of detecting important etiological factors
through multivariate analysis [39]. Having done that,
our results confirmed the finding that hip fracture itself
can cause a significant long-term excess mortality. The
reasons for the association of high long-term excess mor-
tality and hip fracture can be severe post-fractural
complications such as pulmonary embolism, infection,
or cardiovascular events and residual morbidities such
as loss of mobility, chronic pain, and so forth [37].
Although interest in quantifying the impact of risk fac-
tors on the population is increasing among policy makers
in public health, very few studies to date have reported
using PARP to evaluate excess mortality after hip frac-
tures. Tosteson et al. reported PARPs of hip fracture for
excess mortality ranging from 0.5% to 6% [14]. In a study
of osteoporotic fractures, Bliuc et al. reported PARP for
excess mortality to be 18% for lower T-score and 10% for
smoking [34]. In our study, after adjustment for a wide
range of risk factors, hip fracture had the greatest impact
on excess mortality with PARP of 44.7% for short-term
and 48% for long-term mortality. The estimate of PARP of
hip fractures in the present study was much higher than
that in previous studies possibly because of oversampling
of hip fracture patients. However, with an aging popula-
tion and the increasing incidence of hip fractures, our
finding of high PARP of fracture itself strongly supports
the importance in our public health care system of hip
fracture prevention in the elderly and adequate treatment
when it occurs.
Our study has several strengths. First, we incorporated
detailed objective information on as many as 55 covari-
ates. To the best of our knowledge, this study is the first
primary research project focusing on the specific issue of
long-term excess mortality associated with hip fractures.
Second, ours is also the first study using hospital-based
controls with similar comorbid conditions to evaluate
excess mortality of hip fractures. Third, this is the first
study to report the PARP of each covariate for excess
mortality. Fourth, the death data obtained for the present
study were maintained by the government for administra-
tive use and thus were very reliable. In some other studies,
the survival status of the patients obtained by telephone
calls or postcards might be incorrect because of no
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this study were representative of all the hip fracture
patients admitted in our hospital. The patients’ refusal
to join the study was based on their personal choice,
and their baseline conditions were not significantly dif-
ferent from that of the study subjects.
Limitations of the present study should be noted. First,
the study subjects were community-dwelling patients in
one medical center, and so caution is necessary in gener-
alizing the estimate of excess mortality to other popula-
tions. Second, because of the limited number of deaths,
the effects of some risk factors in our study might not
have been detected. The identification of fewer factors in
short-term mortality might be caused by the small num-
ber of deaths in the first year. According to a power
study for the proportional hazards model, the events per
variable should not be less than 10 [40]. In our study,
the number of short-term deaths in the first year was 35,
and only three risk factors were identified. For long-
term death, the number of deaths was 58, and six factors
were identified. Third, low T-score, low BMI, ADL diffi-
culty, and smoking had a significant impact on long-
term excess mortality, but not on short-term mortality.
This finding is somewhat different from previous studies
[33,41-43], possibly because risk factors such as under-
lying health, immobility, etc. might be mutally correlated
and replace one another in the regression models. Fourth,
the lack of BMD data for 21.1% of our patients might re-
duce the accuracy of our risk estimation. Fifth, the excess
mortality estimated in our study might be affected by pa-
tients’ recall bias in responding to the questionnaires.
Sixth, although the age difference between the fracture
and non-fracture groups might be up to 6 years in very
old patients, this would not affect the study results signifi-
cantly. Other possible biases might be also caused by im-
precision of the measurements of the risk factors in both
fractures and non-fractures. However, the misclassification
might be non-differential and tend to result in underesti-
mating the effect of risk factors. Last, in addition to the
mortality risk factors covered in the present study, there
are other potential risk factors that were not included.
However, the present study focused on those factors that
are reliable, easily accessed, and modifiable.
Conclusions
The excess mortality after hip fracture may last longer
than 57 months. Even after adjustment for comorbidities
and other baseline conditions, hip fractures still can result
in both short- and long-term excess mortality. With hip
fracture having the highest impact on excess mortality, its
adequate prevention and treatment should be targeted.
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